tiprankstipranks

BullFrog AI Partners with Sygnature Discovery for AI Innovation

Story Highlights
BullFrog AI Partners with Sygnature Discovery for AI Innovation

Don’t Miss TipRanks’ Half-Year Sale

BullFrog AI Holdings, Inc. ( (BFRG) ) has issued an update.

On June 12, 2025, BullFrog AI Holdings, Inc. announced a strategic collaboration with Sygnature Discovery, a UK-based contract research organization specializing in drug discovery. This partnership will introduce BullFrog’s AI-driven data insights platform, BullFrog Data Networks™, to Sygnature’s global biopharma client base. The collaboration is a significant milestone for BullFrog AI, expected to enhance brand recognition and generate $15-$30 million in revenue through 2028. The initiative aims to accelerate innovation in drug discovery by providing advanced AI tools to small and mid-sized biopharma companies, thereby improving R&D efficiency and success rates.

More about BullFrog AI Holdings, Inc.

BullFrog AI Holdings, Inc. is a technology-enabled drug development company that leverages artificial intelligence and machine learning to facilitate the successful development of pharmaceuticals and biologics. The company focuses on using its proprietary bfLEAP™ platform to analyze complex biological data, aiming to streamline therapeutics development and reduce failure rates in clinical trials.

Average Trading Volume: 388,215

Technical Sentiment Signal: Sell

Current Market Cap: $17.89M

For detailed information about BFRG stock, go to TipRanks’ Stock Analysis page.

Disclaimer & DisclosureReport an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1